Skip to main content
    S

    Select Medical Holdings (SEM)

    Official site

    MEDICAL CARE FACILITIES

    $16.51
    +0.00 (+0.00%)

    Last updated: Jul 01, 2026 at 5:00 PM ET

    Select Medical Holdings (SEM) Financials: Revenue, Profit and Cash Flow

    Updated Apr 30, 2026. Financial statements from company filings, amounts in US dollars.

    Select Medical Holdings reported revenue of $5.45B for the fiscal year ended Dec 31, 2025, up 5.1% from the year before. That year, net income was $214.53M with a net margin of 3.9%, operating cash flow was $346.47M and free cash flow was $117.24M. The quarter ended Mar 31, 2026 had revenue of $1.42B and net income of $63.77M.

    Revenue and Margins

    The operating margin was 6.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $4.22B, a compound annual rate of 2.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$5.45B+5.1%11.5%6.2%3.9%
    Dec 2024$5.19B+7.5%12.2%5.2%5.7%
    Dec 2023$4.83B+4.7%11.8%5.5%6.2%
    Dec 2022$4.61B-25.7%8.7%3.1%4.3%
    Dec 2021$6.20B+12.2%14.8%11.5%8.1%
    Dec 2020$5.53B+1.4%14.8%10.3%6.2%
    Dec 2019$5.45B+7.3%14.9%8.7%3.7%
    Dec 2018$5.08B+16.4%14.6%8.2%3.5%
    Dec 2017$4.37B+3.5%14.4%8.2%5.1%
    Dec 2016$4.22BN/A13.1%7.1%3.0%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 27.7% from the year before. In the quarter ended Mar 2026, net income fell 14.7% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$5.45B$5.19B$4.83B$4.61B$6.20B$5.53B$5.45B$5.08B$4.37B$4.22B
    Cost of revenue$4.82B$4.55B$4.25B$4.21B$5.29B$4.71B$4.64B$4.34B$3.74B$3.67B
    Gross profit$629.29M$633.64M$571.61M$401.49M$919.37M$821.34M$812.92M$740.20M$629.94M$552.09M
    Operating income$336.17M$268.31M$267.24M$144.75M$713.77M$567.66M$471.88M$417.28M$355.88M$299.85M
    Net income$214.53M$296.70M$299.73M$198.03M$499.95M$344.61M$201.03M$176.94M$220.65M$125.27M
    EBITDA$479.61M$475.17M$478.63M$352.85M$920.79M$787.89M$702.55M$641.06M$526.97M$503.46M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Revenue$1.42B$1.40B$1.36B$1.34B$1.35B$1.31B$1.27B$1.28B$1.32B-$179.22M$1.67B$1.67B
    Gross profit$175.47M$145.83M$147.45M$155.45M$180.56M$137.47M$135.87M$159.81M$200.50M-$148.66M$223.19M$250.93M
    Operating income$98.42M$63.94M$72.96M$86.53M$112.75M$21.09M$54.90M$73.86M$118.47M-$173.38M$129.96M$159.20M
    Net income$63.77M$37.74M$44.18M$57.88M$74.73M$3.76M$81.02M$94.77M$117.17M$61.80M$60.82M$91.86M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.83B exceeded cash and equivalents by $1.80B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$5.85B$5.61B$7.69B$7.67B$7.36B$7.66B$7.34B$5.96B$5.13B$4.92B
    Current assets$1.03B$1.02B$1.26B$1.27B$1.14B$1.59B$1.21B$992.52M$920.83M$762.90M
    Cash and equivalents$26.52M$59.69M$52.63M$97.91M$74.31M$577.06M$335.88M$175.18M$122.55M$99.03M
    Total liabilities$3.82B$3.61B$6.12B$6.27B$6.00B$6.00B$5.44B$4.27B$3.55B$3.59B
    Short-term debt$24.22M$20.27M$68.87M$44.35M$17.57M$12.62M$25.17M$43.87M$22.19M$13.66M
    Long-term debt$1.80B$1.69B$3.58B$3.84B$3.56B$3.39B$3.42B$3.25B$2.68B$2.69B
    Shareholder equity$1.71B$1.68B$1.29B$1.12B$1.11B$1.06B$770.97M$803.04M$823.37M$815.73M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total assets$6.04B$5.85B$5.69B$5.74B$5.70B$5.61B$8.00B$7.88B$7.86B$7.69B$7.68B$7.70B
    Total liabilities$3.94B$3.82B$3.67B$3.74B$3.65B$3.61B$5.70B$6.14B$6.19B$6.12B$6.13B$6.17B
    Cash and equivalents$25.68M$26.52M$60.05M$52.35M$53.21M$59.69M$191.47M$111.16M$92.62M$52.63M$77.44M$101.17M
    Shareholder equity$1.76B$1.71B$1.69B$1.67B$1.72B$1.68B$1.92B$1.42B$1.37B$1.29B$1.27B$1.25B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 33.8% of operating cash flow. Dividends and share repurchases together came to 188.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$346.47M$517.86M$582.06M$284.82M$401.23M$1.03B$445.18M$494.19M$238.13M$346.60M
    Capital expenditures$229.22M$222.18M$229.20M$190.37M$180.54M$146.44M$157.13M$167.28M$233.24M$161.63M
    Free cash flow$117.24M$295.69M$352.86M$94.45M$220.69M$881.63M$288.06M$326.91M$4.89M$184.97M
    Dividends paid$121.32M$124.62M$127.44M$107.70M$123.68M$38.59M$21.78M$311.52M$10.62M$3.74M
    Share repurchases$100.08M$37.91M$19.03M$201.40M$740.13M$592.40M$38.53M$6.84M$4.75M$2.93M
    Investing cash flow-$216.49M-$231.01M-$268.48M-$226.34M-$256.59M-$115.35M-$316.73M-$697.14M-$192.97M-$554.32M
    Financing cash flow-$163.15M-$311.17M-$327.48M-$34.89M-$647.38M-$671.54M$32.25M$255.57M-$21.65M$292.31M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Operating cash flow$37.86M$64.33M$175.31M$110.29M-$3.46M$125.43M$180.97M$278.15M-$66.69M$179.44M$116.34M$234.84M
    Capital expenditures$58.90M$59.10M$53.10M$64.68M$52.34M$63.43M$50.68M$55.55M$52.52M$60.60M$50.20M$59.51M
    Free cash flow-$21.04M$5.22M$122.20M$45.61M-$55.80M$62.00M$130.29M$222.60M-$119.21M$118.84M$66.14M$175.32M
    Last 12 quarters

    Frequently Asked Questions About SEM

    What is Select Medical Holdings' annual revenue?

    Select Medical Holdings reported revenue of $5.45B for the fiscal year ended Dec 31, 2025.

    How fast is Select Medical Holdings' revenue growing?

    Revenue was up 5.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.8%.

    Is Select Medical Holdings profitable?

    Yes. Select Medical Holdings reported net income of $214.53M for the fiscal year ended Dec 31, 2025, with a net margin of 3.9%.

    How much free cash flow does SEM generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $346.47M minus capital expenditures of $229.22M produced free cash flow of $117.24M.

    How much debt does Select Medical Holdings have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.80B, short-term debt of $24.22M and cash and equivalents of $26.52M.